Precision BioSciences (STU:PBS0) FFO


STU:PBS0 Precision BioSciences Inc STU:PBS0
45 GF Score
Price €6.84
GF Value €1.59
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Precision BioSciences FFO?

FFO (Funds from operations) only applies to REITs.

STU:PBS0
45GF Score
Precision BioSciences Inc STU:PBS0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Precision BioSciences (STU:PBS0) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of €6.84 is trading 330.2% above its estimated GF Value™ of €1.59. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for STU:PBS0:

  • FFO:
  • GF Value™: €1.59 vs. price of €6.84 (330.2% above fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the STU:PBS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Precision BioSciences Business Description

Other Exchanges DTIL:USA
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
45GF Score

Get the complete analysis for STU:PBS0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.84
Price
€1.59
GF Value